Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
EP02.04 - Early Stage Non-small Cell Lung Cancer - Systemic Therapy
- Type: E-Poster
- Track: Early Stage Non-small Cell Lung Cancer - Systemic Therapy
- Presentations: 10
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP02.04-009 - Real World Survival Outcome Analysis of Adjuvant Therapies in Non-EGFR, Non-ALK Early Stage Resected NSCLC
Author(s): Tedi Hoxha- Abstract
Loading...
-
+
EP03.01 - Epidemiology
- Type: E-Poster
- Track: Epidemiology
- Presentations: 17
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP03.01-002 - Co-occurring Mutations, Smoking Status and Prognosis of Early-stage Resected NSCLCs with EGFR Mutations
Author(s): Alison Moore- Abstract
Loading...
-
+
EP04.01 - Global Health, Health Services Research, and Health Economics - Cost Issues
- Type: E-Poster
- Track: Global Health, Health Services Research, and Health Economics - Cost Issues
- Presentations: 27
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP04.01-001 - Prevalence And Outcomes of EGFR Exon 20 Insertion Mutation In NSCLC: Princess Margaret Cancer Center Experience
Author(s): Abhenil Mittal- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 108
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.01-067 - Rechallenging with PD-1 Inhibitors: Incidence and Management of Immune-Related Adverse Events in Metastatic NSCLC
Author(s): Tuan Hoang- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 171
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.02-082 - Treatment Patterns and Outcomes of First-line Osimertinib-treated Advanced EGFR Mutated NSCLC Patients: A Real-world Study
Author(s): Jae Yun Lee- Abstract
Loading... -
+
EP08.02-079 - The Use of Lung Adenocarcinoma Patient-Derived Xenografts and Organoids to Study GDP-KRAS G12C Inhibitor Resistance
Author(s): Joshua Rosen- Abstract
Loading... -
+
EP08.02-116 - Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors
Author(s): Miguel Villalona Calero- Abstract
Loading...
-
+
OA03 - Molecular Targeted Treatments
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 11
- Moderators:Andrew Ciupek
- Coordinates: 8/07/2022, 14:30 - 15:40, Hall C7
-
+
OA03.04 - Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
14:42 - 14:52 | Author(s): Adrian Sacher
- Abstract
Loading...
-
+
MA14 - Palliative and Supportive Care - The Forgotten Trade
- Type: Mini Oral
- Track: Palliative and Supportive Care
- Presentations: 13
- Moderators:Maria Werner-Wasik
- Coordinates: 8/09/2022, 14:30 - 15:30, Strauss 3
-
+
MA14.08 - Longitudinal Symptoms and Health Utility Scores (HUS) in Patients Receiving PD-1 Inhibitors for Metastatic NSCLC
15:02 - 15:07 | Author(s): Christopher Poletes
- Abstract
Loading...
